A randomized trial comparing 4.8 vs. 2.4 g/day of oral mesalazine for maintenance of remission in ulcerative colitis.
Pica, Roberta
A randomized trial comparing 4.8 vs. 2.4 g/day of oral mesalazine for maintenance of remission in ulcerative colitis. [electronic resource] - Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver Nov 2015 - 933-7 p. digital
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial
1878-3562
10.1016/j.dld.2015.07.011 doi
Administration, Oral
Adult
Aged
Aged, 80 and over
Anti-Inflammatory Agents, Non-Steroidal--administration & dosage
Biopsy
Colitis, Ulcerative--drug therapy
Colonoscopy
Female
Humans
Maintenance Chemotherapy--methods
Male
Medication Adherence
Mesalamine--administration & dosage
Middle Aged
Recurrence
Single-Blind Method
Treatment Outcome
A randomized trial comparing 4.8 vs. 2.4 g/day of oral mesalazine for maintenance of remission in ulcerative colitis. [electronic resource] - Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver Nov 2015 - 933-7 p. digital
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial
1878-3562
10.1016/j.dld.2015.07.011 doi
Administration, Oral
Adult
Aged
Aged, 80 and over
Anti-Inflammatory Agents, Non-Steroidal--administration & dosage
Biopsy
Colitis, Ulcerative--drug therapy
Colonoscopy
Female
Humans
Maintenance Chemotherapy--methods
Male
Medication Adherence
Mesalamine--administration & dosage
Middle Aged
Recurrence
Single-Blind Method
Treatment Outcome